Connection

Co-Authors

This is a "connection" page, showing publications co-authored by LEE M ELLIS and RAY SOMCIO.
Connection Strength

1.144
  1. Effect of molecular therapeutics on liver regeneration in a murine model. J Clin Oncol. 2008 Apr 10; 26(11):1836-42.
    View in: PubMed
    Score: 0.080
  2. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst. 2008 Jan 16; 100(2):109-20.
    View in: PubMed
    Score: 0.079
  3. Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system. Cancer Lett. 2007 Dec 18; 258(2):291-300.
    View in: PubMed
    Score: 0.077
  4. The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res. 2007 Aug 15; 13(16):4704-12.
    View in: PubMed
    Score: 0.076
  5. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. J Clin Invest. 2007 Aug; 117(8):2114-22.
    View in: PubMed
    Score: 0.076
  6. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Ann Surg Oncol. 2007 Oct; 14(10):2838-46.
    View in: PubMed
    Score: 0.076
  7. The role of nitric oxide in mediating tumour blood flow. Expert Opin Ther Targets. 2006 Oct; 10(5):689-701.
    View in: PubMed
    Score: 0.072
  8. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006 Jul 15; 12(14 Pt 1):4147-53.
    View in: PubMed
    Score: 0.071
  9. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. Mol Cancer Ther. 2006 Jul; 5(7):1676-82.
    View in: PubMed
    Score: 0.071
  10. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2628-33.
    View in: PubMed
    Score: 0.070
  11. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res. 2006 Jan 01; 66(1):46-51.
    View in: PubMed
    Score: 0.068
  12. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res. 2005 Sep 01; 65(17):7775-81.
    View in: PubMed
    Score: 0.067
  13. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer. 2005 Jul 15; 104(2):427-38.
    View in: PubMed
    Score: 0.066
  14. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy. Cancer. 2005 Apr 15; 103(8):1561-70.
    View in: PubMed
    Score: 0.065
  15. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene. 2005 Apr 14; 24(16):2647-53.
    View in: PubMed
    Score: 0.065
  16. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann Surg Oncol. 2005 Apr; 12(4):273-81.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.